NCT00195741View on ClinicalTrials.gov

The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

May 31, 2003

Conditions

Migraine

Interventions

DRUG

divalproex sodium

Trial Locations (1)

60064

Global Medical Information - Abbott, North Chicago

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY